Matches in DBpedia 2016-04 for { ?s ?p "Sinopharm Group Company Limited (SEHK: 01099) is the largest pharmaceutical company in China, jointly owned by China National Pharmaceutical Group Corporation and Shanghai Fosun Pharmaceutical. Its revenue in 2007 reached 35 billion RMB ($570 million USD).Sinopharm Group researches and develops, manufactures, distributes, and markets medicine and other healthcare products. Sinopharm Group manages factories, research laboratories, traditional Chinese medicine plantations, and marketing and distribution networks that extend throughout China. It also has 10 subsidiaries and a number of major joint ventures. The company also runs about a dozen retail pharmacy chains. Sinopharm Group, which has operations in Africa, France, Germany, Hong Kong, the US, and Vietnam, was formed in 1998.Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share."@en }
Showing triples 1 to 2 of
2
with 100 triples per page.
- Sinopharm abstract "Sinopharm Group Company Limited (SEHK: 01099) is the largest pharmaceutical company in China, jointly owned by China National Pharmaceutical Group Corporation and Shanghai Fosun Pharmaceutical. Its revenue in 2007 reached 35 billion RMB ($570 million USD).Sinopharm Group researches and develops, manufactures, distributes, and markets medicine and other healthcare products. Sinopharm Group manages factories, research laboratories, traditional Chinese medicine plantations, and marketing and distribution networks that extend throughout China. It also has 10 subsidiaries and a number of major joint ventures. The company also runs about a dozen retail pharmacy chains. Sinopharm Group, which has operations in Africa, France, Germany, Hong Kong, the US, and Vietnam, was formed in 1998.Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share.".
- Q7524930 abstract "Sinopharm Group Company Limited (SEHK: 01099) is the largest pharmaceutical company in China, jointly owned by China National Pharmaceutical Group Corporation and Shanghai Fosun Pharmaceutical. Its revenue in 2007 reached 35 billion RMB ($570 million USD).Sinopharm Group researches and develops, manufactures, distributes, and markets medicine and other healthcare products. Sinopharm Group manages factories, research laboratories, traditional Chinese medicine plantations, and marketing and distribution networks that extend throughout China. It also has 10 subsidiaries and a number of major joint ventures. The company also runs about a dozen retail pharmacy chains. Sinopharm Group, which has operations in Africa, France, Germany, Hong Kong, the US, and Vietnam, was formed in 1998.Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share.".